Available datapackage for study 'The Effect of Tirzepatide on α and β Cell Function and Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus'

This is a study for participants with type 2 diabetes mellitus. The main purpose of this study is to learn more about how tirzepatide, semaglutide and placebo affect the body's ability to respond to blood sugar levels after a meal. The study will last up to 40 weeks, including a 28-week treatment period.

本研究针对2型糖尿病（type 2 diabetes mellitus）患者开展。本研究的核心目标为深入探究替尔泊肽（tirzepatide）、司美格鲁肽（semaglutide）与安慰剂对受试者餐后血糖应答能力的影响。本研究总时长最长可达40周，其中包含28周的治疗周期。